PDUFA V: FDA Could Offer Non-Binding Advice, If It’s Binding
Executive Summary
FDA is interested in giving non-binding advice to drug sponsors under PDUFA V, as long as it is binding, officials told industry.
You may also be interested in...
Tropical Disease Development Partnerships Want More Help From U.S. FDA
The agency’s infrastructure is not attracting many of the Product Development Partnership sponsors, Aeras official says, but new draft guidance could help.
Tropical Disease Development Partnerships Want More Help From FDA
The agency’s infrastructure is not attracting many of the Product Development Partnership sponsors, Aeras official says, but new draft guidance could help.
FDA Could Answer "Clarifying" Questions, But Only For Firms Without Approved Product
The drug industry is not only worried about vulnerable patients, it's worried about vulnerable companies.